Last reviewed · How we verify

NCT02187419

Hypnosis to Improve Sleep In Menopause

Completed NA Last updated 13 April 2017
What this trial tests

NA trial testing Hypnosis in Sleep in 84 participants. Completed in 24 February 2017.

Timeline
1 December 2014
Primary endpoint
24 February 2017
24 February 2017

Quick facts

Lead sponsorBaylor University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment84
Start date1 December 2014
Primary completion24 February 2017
Estimated completion24 February 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor University

Who can join

Adults 40 to 65, female only, with Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine feasibility and adherence to a hypnosis program to improve sleep. It is theorized (based on prior experience and pilot data) that one or more hypnosis program(s) will be feasible and will exhibit acceptable adherence. The programs will assess to determine optimal dose (3 vs 5 sessions) and method (audio-recorded vs therapist delivered).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hypnosis Intervention for Sleep Disturbance: Determination of Optimal Dose and Method of Delivery for Postmenopausal Women.
    Elkins G, Otte J, Carpenter JS, Roberts L, et al · · 2021 · cited 14× · PMID 34047672 · DOI 10.1080/00207144.2021.1919520

Verify or expand the search:

Other trials of Hypnosis

Trials testing the same drug.

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other Baylor University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02187419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing